Cargando…

Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis

BACKGROUND AND OBJECTIVES: Some evidence suggests that bisphosphonates may reduce atherosclerosis, while concerns have been raised about atrial fibrillation. We conducted a meta-analysis to determine the effects of bisphosphonates on total adverse cardiovascular (CV) events, atrial fibrillation, myo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dae Hyun, Rogers, James R., Fulchino, Lisa A., Kim, Caroline A., Solomon, Daniel H., Kim, Seoyoung C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401508/ https://www.ncbi.nlm.nih.gov/pubmed/25884398 http://dx.doi.org/10.1371/journal.pone.0122646

Ejemplares similares

Bisphosphonates and risk of atrial fibrillation: a meta-analysis
por: Kim, Seo Young, et al.
Publicado: (2010)

Patterns of Bisphosphonates Utilization in Patients under Age 45 in a Large Cohort of Commercial Insurance Beneficiaries in the United States
por: Xie, Jing, et al.
Publicado: (2015)

Oral Bisphosphonates and Risk of Subtrochanteric or Diaphyseal Femur Fractures in a Population-Based Cohort
por: Kim, Seo Young, et al.
Publicado: (2011)

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study
por: Kim, Seoyoung C., et al.
Publicado: (2017)

Bisphosphonates and risk of cancers: a systematic review and meta-analysis
por: Li, Yuan-Yuan, et al.
Publicado: (2020)

The Association between Treatment with Bisphosphonates and the Risk of Atrial Fibrillation: A Meta-Analysis of Observational Studies
por: Park, Ji-Hyun, et al.
Publicado: (2022)

Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis
por: Peng, Rui, et al.
Publicado: (2020)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis
por: Yang, Yan-Li, et al.
Publicado: (2019)

The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis
por: Byun, Ji-Hye, et al.
Publicado: (2017)

Risks and benefits of bisphosphonates
por: Coleman, R E
Publicado: (2008)

Bisphosphonates and risk of lung cancer: Protocol for a systematic review and meta-analysis
por: Li, Minghao, et al.
Publicado: (2021)

Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout
por: Desai, Rishi J., et al.
Publicado: (2018)

Are Bisphosphonates Effective in the Treatment of Osteoarthritis Pain? A Meta-Analysis and Systematic Review
por: Davis, Alison J., et al.
Publicado: (2013)

Risk Factors of New Adjacent Compression Fracture after Percutaneous Vertebroplasty: Effectiveness of Bisphosphonate in Osteoporotic or Osteopenic Elderly Patients
por: Seo, Dae-Hyun, et al.
Publicado: (2014)

Effect of low-level laser therapy on bisphosphonate-treated osteoblasts
por: Shin, Sang-Hun, et al.
Publicado: (2016)

Tumour macrophages as potential targets of bisphosphonates
por: Rogers, Thea L, et al.
Publicado: (2011)

Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Bisphosphonate-induced Severe Hypocalcemia - A Case Report -
por: Do, Won-Seok, et al.
Publicado: (2012)

Association of Body Mass Index with Risk of Major Adverse Cardiovascular Events and Mortality in People with Diabetes
por: Lee, Dong Hun, et al.
Publicado: (2018)

The Effect of Polydeoxyribonucleotide Extracted from Salmon Sperm on the Restoration of Bisphosphonate-Related Osteonecrosis of the Jaw
por: Lee, Deok-Won, et al.
Publicado: (2019)

Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jaw
por: Kim, Yun-Ho, et al.
Publicado: (2017)

Cutaneous Abscess as a Complication of Bisphosphonate-Related Osteonecrosis of the Jaw
por: Yang, Min-Young, et al.
Publicado: (2018)

Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report
por: Lee, Jeong Keun, et al.
Publicado: (2013)

Bisphosphonates and Dental Implants: A Systematic Review and Meta-Analysis
por: Sulaiman, Nabaa, et al.
Publicado: (2023)

Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors
por: Seong, Jong-Mi, et al.
Publicado: (2021)

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
por: Bolland, Mark J, et al.
Publicado: (2010)

Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
por: Pawar, Ajinkya, et al.
Publicado: (2021)

Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates
por: Jeong, Ho-Gul, et al.
Publicado: (2017)

Effects of a 'Drug Holiday' on Bone Mineral Density and Bone Turnover Marker During Bisphosphonate Therapy
por: Kong, Sung Yeol, et al.
Publicado: (2013)

Corrigendum: Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jaw
por: Kim, Yun-Ho, et al.
Publicado: (2017)

Bisphosphonates for osteoarthritis
por: Walsh, David A, et al.
Publicado: (2011)

Risk of Cardiovascular Events and Lipid Profile Change in Patients with Breast Cancer Taking Aromatase Inhibitor: A Systematic Review and Meta-Analysis
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis
por: Kaze, Arnaud D., et al.
Publicado: (2022)

Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
por: Kim, Jin-Woo, et al.
Publicado: (2016)

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea
por: Park, So Young, et al.
Publicado: (2021)

Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding ‘risks and benefits of bisphosphonates’
por: Kyrgidis, A, et al.
Publicado: (2009)

The role of bisphosphonates in breast cancer: Development of bisphosphonates
por: Fleisch, Herbert
Publicado: (2002)

Atypical Complete Femoral Fractures Associated with Bisphosphonate Use or Not Associated with Bisphosphonate Use: Is There a Difference?
por: Kim, Sang-Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m5mjo6uf3tli12rm9m2ic0qt4v